Sign In
Buy NDAQ
$77.65
-3.96 (-4.85%)
At Close: Jun 25, 2026
Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:05pm, Friday, 22'nd Nov 2024
BRISBANE, Calif., Nov. 22, 2024 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that on November 18, 2024, the Compensation Committee of Vera's Board of Directors granted in
Carbon Revolution Announces Receipt of Non-Compliance Letter from Nasdaq
04:01pm, Friday, 22'nd Nov 2024
GEELONG, Australia, Nov. 22, 2024 (GLOBE NEWSWIRE) -- Carbon Revolution plc (Nasdaq: CREV) (the “Company”), a Tier 1 OEM supplier and the leading global manufacturer of lightweight advanced techno
ENDRA Life Sciences Regains Compliance with Nasdaq Minimum Bid Price Requirement
08:00am, Friday, 22'nd Nov 2024
ANN ARBOR, Mich.--(BUSINESS WIRE)--ENDRA Life Sciences Inc. (NASDAQ: NDRA), an innovator of Thermo Acoustic Enhanced UltraSound (TAEUS®), today announced that it has regained compliance with the mini
Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:15pm, Thursday, 21'st Nov 2024
MIAMI--(BUSINESS WIRE)---- $SMMT--Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today announced the grant of inducement awards of options to purchase a collective total of
Phoenix Motor Inc. Announces Receipt of Nasdaq Delisting Notice
04:15pm, Thursday, 21'st Nov 2024
ANAHEIM, CA / ACCESSWIRE / November 21, 2024 / Phoenix Motor Inc. (NASDAQ:PEV) (the "Company") today announced that it received a delinquency notification letter from the Listing Qualifications Staff
Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:05pm, Thursday, 21'st Nov 2024
SAN DIEGO , Nov. 21, 2024 /PRNewswire/ -- Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide
Thumzup to Ring the Nasdaq Opening Bell on November 22, 2024
04:05pm, Thursday, 21'st Nov 2024
Los Angeles, CA, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Thumzup Media Corporation ("Thumzup" or the "Company") (Nasdaq: TZUP), a leading provider of innovative social media branding and marketing solutions
Nasdaq Edges Higher; Baidu Shares Fall After Q3 Results
02:39pm, Thursday, 21'st Nov 2024
U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining by more than 500 points on Thursday.
Iterum Therapeutics Regains Full Nasdaq Compliance
08:30am, Thursday, 21'st Nov 2024
Iterum will Continue to be Listed and Traded on the Nasdaq Stock Market Iterum will Continue to be Listed and Traded on the Nasdaq Stock Market
Nasdaq, Wall Street to drop as Nvidia slides after earnings
05:56am, Thursday, 21'st Nov 2024
Wall Street faced a negative start on Thursday in the wake of Nvidia Corp's earnings, which saw the chip-making giant slip almost 3% in pre-market trading. Futures had the Nasdaq down 0.4% ahead of th
Meet the Newest AI Stock in the Nasdaq-100. It Soared 2,140% in 2 Years and Is Still a Buy, According to a Wall Street Analyst.
04:35am, Thursday, 21'st Nov 2024
Meet the Newest AI Stock in the Nasdaq-100. It Soared 2,140% in 2 Years and Is Still a Buy, According to a Wall Street Analyst.
Nasdaq Traders Brace for Volatility as Nvidia's Q4 Guidance Signals Supply Constraints
05:49pm, Wednesday, 20'th Nov 2024
Nvidia Q3 revenue surged 94%, but cautious Q4 guidance and supply concerns sent shares lower. How will this impact AI chips and major market indices?
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
04:30pm, Wednesday, 20'th Nov 2024
NOVATO, Calif., Nov. 20, 2024 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for rar
Adverum Biotechnologies Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
04:05pm, Wednesday, 20'th Nov 2024
REDWOOD CITY, Calif., Nov. 20, 2024 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM) today announced that on November 17, 2024, the Compensation Committee of Adverum's Board of Directo
QQA: Nasdaq 100 Exposure With A 10% Yield
03:49pm, Wednesday, 20'th Nov 2024
The Invesco QQQ Income Advantage ETF combines Nasdaq-100 growth with an options overlay to generate income and protect against market drops. QQA's tech-heavy focus offers high growth potential but als
